Care for young adults with relapsing-remitting MS
Official title: CARE in MS: Childhood Adversity Research Effort in MS
Run by NYU Langone Health · NCT07011914 · Data updated 2026-11-12
This project will test culturally tailored ways to measure childhood adversity and see if past adversity links to blood, MRI, and quality-of-life outcomes in young adults with relapsing-remitting MS, prioritizing Black, Hispanic, and low-income participants.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 29 Years |
| Sex | All |
| Enrollment | 300 (estimated) |
| Sponsor | NYU Langone Health Academic / other |
| Locations | 6 sites (Birmingham, Alabama and 5 other locations) |
| Status | Recruiting |
| Started | October 23, 2025 |
| Main results expected | June 30, 2029 |
| Study ends | June 30, 2029 |
| Registry record updated | October 26, 2026 |
| Trial ID | NCT07011914 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are 18–29-year-olds with relapsing-remitting MS who can read English or Spanish, with an emphasis on those who self-identify as Black, Hispanic, or are low-income and who meet the study's onset and disease-duration windows.
✕Probably not a fit
Older adults, people with progressive forms of MS, non-English/Spanish speakers, or those with disease duration beyond the study limits are unlikely to gain direct benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The project uses community-based participatory research to develop culturally tailored measures of childhood adversity for people with MS. In a cross-sectional arm, eligible young adults with relapsing-remitting MS will attend two visits including a research blood draw and MRI to examine relationships between adversity and clinical, imaging, and laboratory outcomes. A subset of participants will complete interviews and surveys to explore environmental and social factors that affect quality of life among minority and underrepresented MS patients. The work is conducted across multiple U.S. academic sites with involvement from a federal neurological institute.
Why it matters
Potential benefit: If successful, this work could lead to culturally appropriate screening for childhood adversity and more targeted supports that improve outcomes and quality of life for young adults with RRMS.
How similar studies have gone: Previous research has linked childhood adversity to worse MS outcomes, but applying community-based, culturally tailored measurement methods in a young, underrepresented RRMS population is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Aim 1 - * aged ≥18-29 years * diagnosis of RRMS (Fulfill international criteria for relapsing remitting (RRMS)) * 70% self-identifying as a Black, Hispanic, or poverty-impacted (up to 138% of the federal poverty level) individual,and * fluent in English or Spanish. Aim 2 - * aged ≥18-29 years * diagnosis of RRMS (Fulfill international criteria for relapsing remitting (RRMS)) * 70% self-identifying as a Black, Hispanic, or poverty impacted, and * fluent reading in English or Spanish * Pediatric onset MS (MS onset before age 18 and age at time of enrollment is 18-25) OR adult-onset MS (MS onset at age 18 or older and age at time of enrollment is 19-29) * Disease duration below 8 years Aim 3 - Aim 3 will enroll the first 20 participants from Aim 2 who meet the following criteria: * completed at least 80% of study data in the cross-sectional study/Aim 2. * a total of 70% must self-identify as Black, Hispanic, or meet criteria for poverty impacted. * interviews will be evenly split between participants with high (top quartile) and low (bottom quartile) of PROMIS-10 scores. Exclusion Criteria: * Primary or Secondary Progressive MS * Inability to consent. * MS relapse within 30 days prior to study entry * Other major neurologic or psychiatric illness
Where it's running
-
University of Alabama at Birmingham
Birmingham, Alabama, United States Recruiting -
University of California, San Francisco
San Francisco, California, United States Recruiting -
University of Colorado Denver
Aurora, Colorado, United States Recruiting -
Massachusetts General Hospital
Boston, Massachusetts, United States Recruiting -
Cleveland Clinic
Cleveland, Ohio, United States Recruiting -
Baylor College of Medicine
Houston, Texas, United States Recruiting
Study contacts
- Principal investigator: Lauren Krupp, MD — NYU Langone Health
- Study coordinator: Taj Adams
- Email: Taj.Adams@nyulangone.org
- Phone: 646-501-7528
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Treadmill-based virtual reality walking training for MS patients
This study tests whether a treadmill with virtual reality and smart socks can help people with multiple sclerosis walk better and feel safer in daily life.
-
Virtual Reality and Mental Practice to Improve Balance and Walking in Relapsing MS
This study tests whether virtual reality training or mental practice can improve balance and walking in people with relapsing–remitting multiple sclerosis.
-
REAL-MS: A Look at Autologous Stem Cell Transplant vs High-Efficacy MS Therapies in Real-World Care
This study tests how AHSCT compares to high-efficacy MS medicines in adults treated in routine clinical care.
-
Tolebrutinib in real-world MS care for patients treated by clinicians
This real-world study sees how tolebrutinib is used for multiple sclerosis patients and what outcomes look like in everyday practice.
-
Pilates via live video vs. prerecorded videos for people with multiple sclerosis
This study tests whether live, coach-led Pilates sessions through video calls are more beneficial than prerecorded Pilates videos for adults with MS.
-
Cooling During Inpatient Rehab for People with MS
This trial tests whether wearing a cooling vest during intensive training can reduce fatigue and improve walking, strength, balance, and cognition in people with multiple sclerosis during a 3-week inpatient rehab stay.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.